A medication that can treat Trichomoms infection has been approved for use in the U.S. for the first time, potentially saving millions of people who are at risk of getting the parasitic infection.
The drug, called Tricho, can be used as a treatment for Trichomyces, which causes the infection.
It is a treatment that was approved by the Food and Drug Administration for the treatment of Trichsocybe, a fungus, in March.
It was approved for the prevention of trichomonosis in January, and now it is eligible for use as a cure.
It could help prevent the disease, said Dr. Eric Karp, a specialist in infectious diseases at the University of Pennsylvania Medical Center.
The Drug Enforcement Administration said Trichobacteria are considered a global threat.
It has been estimated that about 1.5 million Americans could get Trichospasmosis every year.
It can cause serious illness, including blindness and respiratory failure, and kills more than 100,000 Americans annually.
The CDC says the fungus can cause infections, such as trichotoxa, trichocephaly, trisomy 13 and trichomellosis, that affect the heart, brain, skin and eyes.
Karp said Trachophores infections have killed more than 10,000 people worldwide.
It’s not clear how Trichorophores is transmitted, but the fungus is the same species as Trichotoxin.
The FDA said the drug can be administered intravenously, and it’s currently being tested for safety.
It will be available in stores beginning in the fall.